... Funding Opportunity Number: PD-14-1415 Opportunity Category: Discretionary Funding Instrument Type: Grant Category of Funding Activity: Science and Technology and…
Super UserApril 9, 2013
... Funding Opportunity Number: PA-13-183 Opportunity Category: Discretionary Funding Instrument Type: Grant Category of Funding Activity: Food and NutritionHealth CFDA…
Super UserApril 9, 2013
Pictured: Rich Bendis, BHI; Arkesh Mehta, Chikujee Therapeutics; Stephen Yoder, Pieras AG; Rick Soni, Rexahn Pharmaceuticals Growlers was “abuzz” on…
Super UserApril 5, 2013
On April 2, BHI invited a team of NIH Office of Technology Transfer interns working with BHI EIR Todd Chappell…
Super UserApril 5, 2013
(more…)
BHI AdministratorMarch 28, 2013
- Multiple SBIR/STTR Submission Deadlines Quickly Approaching - BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant…
Super UserMarch 25, 2013
Rick Soni is the President and Chief Operating Officer of Rexahn Pharmaceuticals, a publically-traded clinical stage biopharmaceutical company. He has…
Super UserMarch 21, 2013